1 / 6

Breast Imaging Technologies Market Insights on Market Challenges and New Trends

The global breast imaging technologies market size was valued at $2,544 million in 2015 and is expected to reach $4,502 million by 2022, growing at a CAGR of 8.4% during the study period.

Download Presentation

Breast Imaging Technologies Market Insights on Market Challenges and New Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Breast Imaging Technologies Market

  2. Increasing prevalence of breast cancer, rapid technological advancements, and increase in awareness regarding breast cancer have boosted the growth of the global breast imaging technologies market. However, high cost of breast cancer detection imaging modalities and stringent regulatory approval procedure hamper the market growth. On the contrary, untapped markets in the emerging countries are expected to create lucrative opportunities in the near future. The Global Breast Imaging Technologies Market accounted for $2.54 billion in 2015 and is expected to reach $4.50 billion by 2022, registering a CAGR of 8.4% during the study period. Get Sample Report

  3. Global breast imaging technologies market is divided on the basis of product type and region. Based on product type, the market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing breast imaging technologies segment held the largest share in 2015, owing to its ability to identify breast imaging tools facilitate faster interpretation of breast tissues and create less false positive results as compared to MRI. However, the non-ionizing breast imaging technologies segment is expected to manifest the fastest CAGR through 2022, owing to introduction of better imaging models including automated whole breast ultrasound system (ABUS). Moreover, these techniques use infrared radiations, which have a better chance of reducing the risk of the development of radiation-induced cancer.

  4. The ionizing breast imaging technologies segment is further divided into analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone beam computed tomography (CBCT), and positron emission mammography (PEM). The full-field digital mammography systems segment held the largest share in 2015, as it is time efficient and needless radiation dose than other technologies. Moreover, radiologists can adjust the brightness of the breast image, making it easier to observe the breast tissues. However, the 3D breast tomosynthesis segment is estimated to register the fastest CAGR during the forecast period, as this method offers easy detection of breast cancer in women with dense breast tissues.

  5. Key findings of the Breast Imaging Technologies Market : • The ionizing breast imaging segment accounted for almost two-thirds of the total market in 2015, while non-ionizing breast imaging technologies is expected to be the fastest growing segment, recording a CAGR of 9.2% during the forecast period. • Full-field digital mammography system accounted for more than three-fourths of the total ionizing breast imaging technologies market in 2015. • 3D breast tomosynthesis segment is expected to grow with the highest CAGR of 9.9%.

  6. The report includes analysis of the major market players such as FUJIFILM Holdings Corporation, Dilon Technologies, Inc., General Electric Company, Gamma Medica, Inc., Koning Corporation, Hologic, Inc., Siemens AG, Koninklijke Philips N.V., Sonocin, Inc., and Toshiba Corporation.

More Related